Cargando…
Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro
Gemcitabine resistance is a common problem of pancreatic cancer chemotherapy, and how to reverse it plays an important role in the treatment of pancreatic cancer. This study investigated the effect of emodin on the gemcitabine-resistant pancreatic cancer cell line SW1990/Gem, and explored the potent...
Autores principales: | LIU, DIAN-LEI, BU, HEQI, LI, HONG, CHEN, HUI, GUO, HONG-CHUN, WANG, ZHAO-HONG, TONG, HONG-FEI, NI, ZHONG-LIN, LIU, HAI-BIN, LIN, SHENG-ZHANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584653/ https://www.ncbi.nlm.nih.gov/pubmed/22159556 http://dx.doi.org/10.3892/ijo.2011.1285 |
Ejemplares similares
-
Antitumor Activity of Emodin against Pancreatic Cancer Depends on Its Dual Role: Promotion of Apoptosis and Suppression of Angiogenesis
por: Lin, Sheng-Zhang, et al.
Publicado: (2012) -
Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway
por: Wei, Wei-Tian, et al.
Publicado: (2011) -
Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition
por: Wei, Weitian, et al.
Publicado: (2022) -
Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway
por: Tong, Hongfei, et al.
Publicado: (2020) -
Protective Effects of Emodin-Induced Neutrophil Apoptosis via the Ca(2+)-Caspase 12 Pathway against SIRS in Rats with Severe Acute Pancreatitis
por: Wang, Gui-Jun, et al.
Publicado: (2016)